LGALS3 and acute myeloid leukemia: It would also be interesting to evaluate the effect of Gal-3 knockdown in AML patient-derived BM-MSCs and relapsed/refractory AML patient-derived BM-MSCs on AML cell survival, proliferation, and migration.